| Sibson K, Steward C, Moppett J, et al.
Dismal long-term prognosis for children with refractory acute myeloid leukaemia treated with gemtuzumab ozogamicin and stem cell transplantation: where now? [JOURNAL ARTICLE]
Br J Haematol 2009 May 26.
Full Citation | Find Related Articles |
| Duong HK, Sekeres MA
Targeted treatment of acute myeloid leukemia in older adults: role of gemtuzumab ozogamicin. [Journal Article]
Clin Interv Aging 2009; 4(1):197-205.
Abstract | Full Citation |
| Haag P, Viktorsson K, Lindberg ML, et al.
Deficient activation of Bak and Bax confers resistance to gemtuzumab ozogamicin-induced apoptotic cell death in AML. [JOURNAL ARTICLE]
Exp Hematol 2009 Jun; 37(6):755-766.
Abstract | Full Citation | Find Related Articles |
| Doubek M, Palasek I, Pospisil Z, et al.
Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB, or MLL gene translocations: Frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression. [Journal Article]
Exp Hematol 2009 Jun; 37(6):659-72.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Shipley JL, Butera JN
Acute myelogenous leukemia. [JOURNAL ARTICLE]
Exp Hematol 2009 Jun; 37(6):649-658.
Abstract | Full Citation |
| Maradei SC, Maiolino A, de Azevedo AM, et al.
Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation. [JOURNAL ARTICLE]
Blood 2009 Apr 28.
Abstract | Full Citation | Find Related Articles |
| Unal S, Cakir M, Kuşkonmaz B, et al.
Successful treatment with gemtuzumab ozogamicin monotherapy in a pediatric patient with resistant relapse of acute myeloid leukemia. [Journal Article]
Turk J Pediatr 2009 Jan-Feb; 51(1):69-71.
Abstract | Full Citation | Find Related Articles |
| Kobayashi Y, Tobinai K, Takeshita A, et al.
Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia: final results of Japanese multicenter cooperative study. [JOURNAL ARTICLE]
Int J Hematol 2009 Apr 10.
Abstract | Full Citation | Find Related Articles |
| O'Reilly MK, Paulson JC
Siglecs as targets for therapy in immune-cell-mediated disease. [JOURNAL ARTICLE]
Trends Pharmacol Sci 2009 Apr 7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Ten Cate B, Bremer E, de Bruyn M, et al.
A novel AML-selective TRAIL fusion protein that is superior to Gemtuzumab Ozogamicin in terms of in vitro selectivity, activity and stability. [JOURNAL ARTICLE]
Leukemia 2009 Mar 5.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
  |
